A carregar...
A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma
Adult T-cell leukemia/lymphoma (ATL) is a malignancy of peripheral T-lymphocytes with a poor prognosis. This multicenter, two-stage, single-arm, phase II study assessed the efficacy and safety of bortezomib in patients with relapsed/refractory ATL who received at least one regimen of chemotherapy. T...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4582992/ https://ncbi.nlm.nih.gov/pubmed/26179770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12735 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|